Genetic engineering for haemophilia A.

about

Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo.In vivo models of haemophilia - status on current knowledge of clinical phenotypes and therapeutic interventions.

P2860

Q33713295-2120DC0B-6FB7-4564-8391-1EAB468FFB15 Q37056724-3953EC37-F245-4E35-B1C7-DB6550EF7C09

P2860

Genetic engineering for haemophilia A.

Item

http://www.wikidata.org/entity/Q36600245

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Genetic engineering for haemophilia A.

@ast

Genetic engineering for haemophilia A.

@en

type

Item

label

Genetic engineering for haemophilia A.

@ast

Genetic engineering for haemophilia A.

@en

prefLabel

Genetic engineering for haemophilia A.

@ast

Genetic engineering for haemophilia A.

@en

P1476

Genetic engineering for haemophilia A.

@en

P2093

Oi Lian Kon

http://www.w3.org/2001/XMLSchema#string

Roy Y Calne

http://www.w3.org/2001/XMLSchema#string

Shu Uin Gan

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal stem cells avoid allogeneic rejection

Human mesenchymal stem cells modulate allogeneic immune cell responses

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.

Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A.

Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy.

Inhibitors: resolving diagnostic and therapeutic dilemmas.

Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.

Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives.

Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.

P304

1023-1030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.6.10.1023

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16989584

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia A

Genetic engineering for haemophilia A.

about

P2860

P2860

Genetic engineering for haemophilia A.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921